Attached files

file filename
EX-32 - EXHIBIT 32 - ICU MEDICAL INC/DEexhibit32123117.htm
EX-31.2 - EXHIBIT 31.2 - ICU MEDICAL INC/DEexhibit312123117.htm
EX-31.1 - EXHIBIT 31.1 - ICU MEDICAL INC/DEexhibit311123117.htm
EX-21 - EXHIBIT 21 - ICU MEDICAL INC/DEexhibit21subsidiariesofreg.htm
EX-10.15 - EXHIBIT 10.15 - ICU MEDICAL INC/DEexhibit1015non-employeedir.htm
EX-10.14 - EXHIBIT 10.14 - ICU MEDICAL INC/DEexhibit1014executiveoffice.htm
10-K - 10-K - ICU MEDICAL INC/DEicui1231201710-k.htm


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-04171, 333-58024, 333-90462, 333-90464, 333-115654, 333-115653, 333-04167, 333-175239, 333-198256, and 333-219106 on Form S-8 of our reports dated March 16, 2018, relating to the financial statements and financial statement schedule of ICU Medical, Inc. and subsidiaries, and the effectiveness of ICU Medical Inc. and subsidiaries’ internal control over financial reporting, appearing in this Annual Report on Form 10-K of ICU Medical, Inc. for the year ended December 31, 2017.

/s/ Deloitte & Touche LLP
 
 
 
Costa Mesa, California
 
March 16, 2018